Castleview Partners »

Arcturus Therapeutics Hldg I shares owned by Castleview Partners

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Castleview Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $130k 17k 7.72

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate (MBSF)
Advisor Managed Portfolios Regan Fixed Rate (MBSX)
ConocoPhillips (COP)
Apple (AAPL)
Tesla Motors (TSLA)
Managed Portfolio Series Leuthold Select (LST)
Bristol Myers Squibb (BMY)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Advisors Inner Circle Fd Ii Pmv Adaptive Rsk (ARP)
Home Depot (HD)
Kkr & Co (KKR)
Vaneck Etf Trust Real Assets Etf (RAAX)
Fidelity Covington Trust High Divid Etf (FDVV)
Amgen (AMGN)
UnitedHealth (UNH)

View all positions for Castleview Partners

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
ARK Investment Management
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Vanguard Group
Vanguard Capital Management
Two Sigma Investments
Vanguard Portfolio Management
Geode Capital Management
State Street Corporation
Millennium Management
UBS Group
Empire Life Investments
Dimensional Fund Advisors

View all funds holding Arcturus Therapeutics Hldg I